logo

Quick Facts

Share SHARE

TransUnion, global risk and information solutions provider, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission to raise up to $100 million in an initial public offering of common shares. The company did not specify the number of shares to be sold and the...

Mylan (MYL) announced the U.S. launch of Amlodipine and Valsartan Tablets, 5 mg/160 mg, 5 mg/320 mg, 10 mg/160 mg, 10 mg/320 mg, which is the generic version of Novartis' Exforge Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application...

International Paper (IP) announced it has reached a definitive agreement with MeadWestvaco Corp. (MWV) to sell the Carolina coated bristols brand. The company's decision to sell the Carolina brand was a result of its plans to convert the Riegelwood N.C., Mill to 100 percent fluff and softwood pulp production,...

Berry Genomics Co., Ltd. announced that Hangzhou Berry Genomics, a subsidiary of Berry Genomics Co., Ltd., has received premarket clearance from the Chinese Food and Drug Administration or CFDA for the NextSeq CN500, a high throughput sequencing instrument developed with Illumina (ILMN) to meet Chinese...

UK-based drugmaker AstraZeneca Plc. (AZN, AZN.L) Tuesday said MOVANTIK (naloxegol) has been launched in the U.S. On September 16, 2014, the US Food and Drug Administration approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist or PAMORA medication for the...

United States Steel Corp. (X) announced the company will adjust operations and temporarily idle a portion of its Minnesota Ore Operations - Minntac plant in Mt. Iron, Minn., effective June 1. The company's action is due to the current inventory levels and ongoing adjustment of its steelmaking operations...

Teva Pharmaceutical Industries Ltd. (TEVA) reported the launch of the generic equivalent to Exforge (amlodipine and valsartan) tablets in four different strengths, in the U.S. Exforge (amlodipine and valsartan) tablets are used in the treatment of high blood pressure (hypertension), a chronic condition...

Charter Communications, Inc. (CHTR) and its subsidiary, CCH I, LLC, (together, the New Charter), and Advance/Newhouse Partnership (the parent company of Bright House Networks, LLC) announced a definitive agreement, whereby Charter will acquire Bright House Networks for $10.4 billion. The business...

Raytheon Company (RTN) said it has received a $528 million fixed-price incentive, firm target contract modification for Advanced Medium Range Air-to-Air Missiles or AMRAAM. Raytheon will provide AMRAAM Lot 29 missiles and other AMRAAM system items. This contract involves foreign military sales. The...

SkyPeople Fruit Juice Inc. (SPU), a producer of fruit juice concentrates, fruit juice beverages and other fruit-related products, reported that net income attributable to shareholders for the fiscal year 2014 was $7.9 million, a decrease of 35% from $12.2 million in fiscal 2013, while earnings per share...

Deloitte and Verizon Enterprise Solutions announced a strategic alliance to deliver a comprehensive set of security and risk-management solutions to help businesses prepare, respond and recover more efficiently, effectively, and thoroughly when a cyberattack occurs. According to officials from Deloitte...

E-Commerce China Dangdang Inc. (DANG), business-to-consumer e-commerce company in China, reported that its net income attributable to common Shareholders for the fourth quarter ended December 31, 2014 was RMB32.8 million or $5.3 million, representing a 51.4% increase from RMB21.7 million in the corresponding...

GridLiance GP LLC and Blackstone Energy Partners, an affiliate of The Blackstone Group L.P. (BX) announced the formation of GridLiance, the nation's first competitive transmission company focused on collaborating with under-served U.S. municipal, cooperative and joint action agency utilities to jointly...

Syndax Pharmaceuticals, Inc. and Merck (MRK) announced they have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining Syndax's entinostat, an investigational epigenetic therapy, with Merck's KEYTRUDA (pembrolizumab), the first anti-PD-1 therapy approved in the...

Cleantech Solutions International, Inc. (CLNT) said fourth-quarter net income grew to $3.0 million, or $0.79 per share from $2.1 million, or $0.60 per share, a year-ago. Adjusted net income for the current quarter was $2.0 million or $0.51 per share, down from $4.7 million or $1.34 per share in the...

Follow RTT